Manuel B. Garcia

Manuel B. Garcia serves as the Senior Director for Educational Technology and Digital Learning at FEU Institute of Technology, Manila, Philippines. Read More

Contact Info

1607, FEU Tech Building,
P. Paredes St, Sampaloc,
Manila, Philippines
mbgarcia@feutech.edu.ph

Follow Me

What Makes a Comparison Group Credible in a Quasi-Experiment?

A comparison group is not credible merely because it resembles the intervention group. Learn how assignment mechanisms, untreated outcome trajectories, eligibility, and exposure differences determine whether a comparison can support causal inference.

222
Choosing a Credible Comparison Group Guide 222 of 1272
01 · The Question

How Do You Know Whether an Untreated Group Is a Valid Comparison for an Intervention Group?

Suppose five universities introduce an AI-supported academic advising system, while five other universities continue their existing advising services.

You plan to compare student retention across the two groups. To improve comparability, you select universities with similar enrollment numbers, institutional classifications, and geographic locations.

Does this make the untreated universities credible comparison groups?

Not necessarily. Universities with similar enrollment and location may differ in student motivation, financial assistance, institutional leadership, or pre-existing retention trends. These differences could influence outcomes even without the advising system.

The challenge is not simply to find institutions that look alike. It is to establish whether their observed outcomes provide a defensible approximation of what would have happened to the intervention institutions without treatment.

02 · The Short Answer

A Credible Comparison Group Must Support the Intended Counterfactual

In Brief

A comparison group is credible in a quasi-experiment when its selection, treatment exposure, outcome measurement, and relevant characteristics support a defensible estimate of what would have happened to the treated group without the intervention, under the assumptions of the chosen design.

Baseline similarity may be helpful, but it is not sufficient by itself. Researchers should investigate why groups received different treatment conditions, whether their untreated outcome trajectories are plausibly comparable, whether important confounders or concurrent interventions differ, and whether the comparison group represents the population relevant to the intended causal effect.

03 · What You Need to Know

How to Evaluate the Credibility of a Quasi-Experimental Comparison Group

The comparison group represents an unobserved alternative

In causal research, the outcome that a treated individual or institution would have experienced without treatment is counterfactual.

Researchers cannot ordinarily observe both treatment and non-treatment outcomes for the same unit at the same relevant time.

A comparison group provides information that may help estimate the missing outcome.

For example, universities that did not adopt an AI advising system may provide evidence about retention changes that could have occurred without the intervention.

However, the untreated universities are not automatically equivalent to the treated universities.

The credibility of the comparison depends on whether the design's assumptions justify using their outcomes to approximate the treated group's counterfactual.

Why baseline similarity is not enough

Researchers often select comparison institutions based on observable characteristics such as enrollment, geographic region, institutional type, or baseline achievement.

These characteristics may be useful because they are associated with outcomes or intervention adoption.

However, similarity on a limited set of observed variables does not guarantee similarity in unobserved determinants of outcomes.

Two schools may have nearly identical baseline achievement but differ in teacher turnover, instructional leadership, parental involvement, or planned curriculum reforms.

If those differences influence subsequent achievement, the schools may follow different trajectories without the intervention.

Consequently, a comparison group should be assessed according to the identification assumptions of the design rather than a generic requirement that baseline means be similar.

What makes a comparison credible depends on the design

Different quasi-experimental designs require different forms of comparability.

Difference-in-differences relies on assumptions about counterfactual outcome changes. Regression discontinuity relies on local continuity around an assignment cutoff. Interrupted time-series designs rely on assumptions about how outcomes would have evolved without intervention.

Design Relevant comparison Key credibility question
Difference-in-differences Treated and untreated or not-yet-treated groups observed over time Would their outcomes have changed comparably without treatment, under the specified assumptions?
Regression discontinuity Units immediately around an assignment cutoff Are relevant potential outcomes continuous at the threshold apart from the treatment discontinuity?
Controlled interrupted time series Repeated treated and comparison outcome series Does the comparison series represent relevant background changes without being affected by treatment?
Matching-based observational causal analysis Units with similar measured pretreatment covariates Are relevant confounders adequately measured, and is there sufficient overlap?
Staggered rollout evaluation Appropriate not-yet-treated or never-treated units Is adoption timing compatible with the required counterfactual assumptions?

A comparison suitable for one design may be inappropriate for another. Researchers should therefore identify the causal strategy before declaring that the comparison group is credible.

Why the treatment assignment mechanism matters

The first question should be why some units received the intervention and others did not.

Was treatment assigned according to eligibility, administrative readiness, voluntary participation, geographic location, or policy timing?

These mechanisms can create systematic differences between treated and comparison units.

For example, universities adopting an AI advising system may have stronger digital infrastructure and more experienced administrative personnel.

Those characteristics may independently influence retention.

Researchers should investigate whether the comparison group differs on factors that determine both treatment receipt and potential outcomes.

The allocation mechanism often provides more information about causal credibility than a table of demographic similarities alone.

Why comparable outcome trajectories may matter more than identical baseline levels

In difference-in-differences research, the central identifying assumption concerns counterfactual outcome trends rather than equal outcome levels.

Two universities may have different baseline retention rates but similar changes over time in the absence of treatment.

Conversely, two universities may have identical baseline retention rates while following different underlying trajectories.

The latter situation can be particularly problematic for a difference-in-differences analysis.

Consider two hypothetical universities with the following pre-intervention retention rates:

University Year 1 Year 2 Year 3
University A 70% 75% 80%
University B 78% 79% 80%

Both universities have 80% retention in Year 3, but University A improved by five percentage points annually while University B improved by one.

If University A adopts an intervention after Year 3, University B's future outcome trajectory may not provide a credible counterfactual without additional justification.

This example demonstrates why matching on the latest baseline outcome alone can be misleading.

Nevertheless, observed pre-intervention trends cannot prove the parallel trends assumption for the unobserved post-intervention period.

How eligibility criteria affect comparison credibility

Treated and comparison populations should be defined using eligibility criteria appropriate to the intended estimand.

Suppose an AI tutoring intervention is offered only to first-year students who fail a diagnostic assessment.

Comparing these students with all students who did not receive tutoring would combine differences in treatment exposure with differences in academic need and eligibility.

A more defensible comparison might involve students subject to the same eligibility rules but not receiving treatment for reasons compatible with a particular identification strategy.

In regression discontinuity, for example, students immediately around an eligibility threshold may provide a local comparison under continuity assumptions.

Researchers should define who could have received the intervention and why some eligible units remained untreated.

Why common measurement procedures matter

A comparison group may be similar in relevant characteristics but still be unsuitable if outcomes are measured differently.

For example, intervention schools may use a new digital assessment while comparison schools use a conventional examination.

Differences in observed scores may then reflect assessment format or measurement properties rather than the intervention.

Researchers should examine whether outcome definitions, measurement instruments, assessment schedules, and data collection procedures are sufficiently comparable.

Changes in administrative reporting or participant eligibility can also create artificial differences over time.

Measurement comparability is therefore part of counterfactual credibility, not merely a data management concern.

Why contamination and spillover can undermine comparison groups

Comparison units should not be assumed untreated simply because they were not formally assigned the intervention.

Students may share digital learning materials across classes. Teachers may adopt instructional practices learned from colleagues in intervention schools. Institutional policies may influence nearby campuses.

Such spillover can change comparison outcomes and complicate interpretation.

For example, if teachers in comparison schools receive informal training from intervention teachers, their students may benefit from elements of the intervention.

The resulting estimate may represent the effect of formal program assignment under spillover rather than the effect of exposure in a setting without interference.

Researchers should identify plausible contamination pathways and determine whether the intended estimand remains meaningful.

Why concurrent interventions are particularly problematic

Suppose intervention universities introduce an AI advising system while simultaneously expanding financial assistance.

If comparison universities do not receive the financial assistance, differences in retention may reflect both changes.

Researchers should distinguish the intervention being evaluated from other policies introduced at the same time.

If the policies always occur together, the data may support estimation of a combined package effect rather than the separate effect of the advising system.

Calendar-time adjustment alone cannot necessarily separate interventions that are perfectly aligned across institutions and periods.

Credible comparison selection therefore requires understanding institutional policy histories, not simply matching baseline characteristics.

How matching can improve comparison quality

Matching attempts to identify treated and untreated units with similar measured pretreatment characteristics.

Researchers may match schools on baseline achievement, enrollment, geographic region, or other prognostic factors.

Propensity-score methods summarize the estimated probability of treatment conditional on measured covariates and can support particular matching or weighting strategies.

However, matching does not automatically create randomization.

Its causal interpretation depends on assumptions about measured confounding, overlap, treatment definition, and the analysis.

Researchers should not select comparison units solely because a matching algorithm produces small numerical differences on observed variables.

Why overlap matters

Overlap, sometimes called positivity, concerns whether units with relevant covariate profiles have a meaningful possibility of receiving either treatment condition.

Suppose every large university adopts an AI advising system and every small university remains untreated.

The dataset may contain no untreated large universities from which to estimate the counterfactual outcome for large treated universities without substantial extrapolation.

Statistical models can produce predictions in such settings, but those predictions may depend heavily on assumptions unsupported by comparable observations.

Researchers should examine the distribution of relevant characteristics and identify regions where treated and comparison units overlap.

Restricting analysis to an overlap population may improve credibility but can change the target estimand and limit generalizability.

Why comparison groups should be selected before examining treatment effects

Researchers may be tempted to compare several possible untreated groups and retain the one producing the strongest or most statistically significant intervention effect.

This introduces analytical flexibility and can undermine the credibility of the findings.

Comparison selection should be guided by the assignment mechanism, substantive knowledge, pretreatment characteristics, and design assumptions.

Where feasible, researchers should prespecify the primary comparison and criteria for including or excluding units.

Alternative comparison groups may be used in sensitivity analyses, but their selection and interpretation should be transparent.

A credible comparison should be chosen because it supports the counterfactual, not because it produces a desirable result.

Why post-treatment variables should not automatically be used for matching

Matching variables should generally be measured before intervention exposure when they are intended to address baseline confounding.

Variables measured after treatment may themselves be affected by the intervention.

For example, student engagement after implementation may partly reflect the effect of an AI tutoring platform.

Matching intervention and comparison students on post-treatment engagement could remove part of the effect researchers seek to estimate or introduce bias through conditioning on a consequence of treatment.

Researchers should distinguish pretreatment confounders from mediators, colliders, and other post-treatment variables using substantive causal reasoning.

When not-yet-treated units can serve as comparisons

In staggered intervention rollouts, institutions scheduled to adopt the program later may serve as comparisons for institutions that have already adopted it.

However, not-yet-treated status alone does not establish comparability.

Early and late adopters may differ in readiness, resources, anticipated outcomes, or institutional priorities.

Researchers should examine whether the required counterfactual trends are plausible and whether anticipation or preparatory activities affect outcomes before formal implementation.

Once later adopters receive the intervention, they no longer provide untreated concurrent observations.

Modern staggered difference-in-differences approaches can define appropriate comparison sets and treatment-effect aggregation strategies, but their causal validity remains conditional on identification assumptions.

When a comparison series is useful in interrupted time-series research

Controlled interrupted time-series designs use repeated outcomes from a comparison population or outcome series alongside the treated series.

A useful comparison series should capture relevant background changes without being affected by the intervention.

For example, a comparable university that did not introduce an advising policy may help identify broader changes in retention occurring during the same period.

However, the comparison university may experience different policy changes or student population shifts.

Researchers should examine the similarity of prior trends, measurement consistency, exposure status, and concurrent events.

The advantages of controlled interrupted time-series designs depend on the credibility of the control, not simply its presence.

How negative controls can help assess comparison credibility

Negative controls are outcomes or exposures that, under a specified causal argument, should not be affected by the intervention but may reveal particular sources of bias.

For example, researchers might examine an outcome that should not plausibly respond to the educational intervention but is subject to similar institutional confounding.

An unexpected association could suggest that the comparison remains affected by factors other than treatment.

However, choosing a valid negative control requires substantive justification. An outcome assumed unaffected may actually respond indirectly to the intervention.

Negative control findings can strengthen or challenge an identification argument, but they do not automatically establish that all confounding has been removed.

What if no credible comparison group exists?

Some interventions are introduced in ways that make a credible untreated comparison difficult to construct.

For example, every university in a system may adopt a new policy simultaneously, while other institutions differ substantially in student populations and reporting procedures.

Researchers may consider alternative identification strategies, including interrupted time series, regression discontinuity, or other approaches suited to the assignment mechanism.

However, an alternative design is useful only when its assumptions can be defended.

If no credible counterfactual can be established, the study may still provide descriptive, implementation, or associational evidence.

Researchers should avoid presenting an unsuitable comparison group as valid merely because the research question requires one.

Watch Out

A comparison group can be similar to the intervention group on every variable in a baseline table and still provide a poor counterfactual. Comparability must be evaluated in relation to the assignment mechanism, outcome trajectories, unmeasured factors, and assumptions of the chosen design.

04 · A Practical Example

Choosing Between Two Potential Comparison Groups for an AI Advising Evaluation

Hypothetical Example

Universities with similar baseline retention but different historical trends

A university adopts an AI-supported advising system after three years of improving student retention.

The researcher identifies two possible comparison universities. Comparison A has nearly identical retention immediately before implementation but a different historical trajectory. Comparison B has lower retention but a historical trajectory more similar to that of the intervention university.

The following percentages are hypothetical.

University Year 1 Year 2 Year 3 Pre-intervention pattern
Intervention university 70% 75% 80% +5 points per year
Comparison A 78% 79% 80% +1 point per year
Comparison B 60% 65% 70% +5 points per year
Examine baseline levels. Comparison A matches the intervention university's Year 3 retention rate of 80%, while Comparison B is ten percentage points lower.
Examine historical changes. The intervention university and Comparison B both improve by five percentage points annually. Comparison A improves by only one.
Identify the proposed design. The researcher considers difference-in-differences, for which counterfactual trends are particularly important.
Investigate institutional differences. The researcher examines admissions, student support policies, financial assistance, and other determinants of retention.
Evaluate the comparison. Comparison B may be more promising for a parallel-trends argument, despite its different baseline level, but the observed trends do not establish the assumption.
Prespecify and test robustness. The primary comparison is justified using pretreatment evidence, with sensitivity analyses examining alternative comparison choices and assumptions.

Interpretation: Comparison A appears more similar at the latest baseline measurement, but Comparison B has a more similar observed trajectory.

For difference-in-differences, this may make Comparison B more useful, provided there are defensible reasons to expect comparable untreated changes after implementation.

However, three pre-intervention observations cannot prove future parallel trends. If Comparison B is subject to different policies or institutional changes, it may still be unsuitable.

The example demonstrates why credible comparison selection must follow the identification strategy rather than a simple search for matching baseline averages.

05 · What Researchers Often Get Wrong

Common Mistakes When Selecting Quasi-Experimental Comparison Groups

Misconception

Similar Baseline Means Guarantee a Credible Comparison

Similar outcome levels do not establish similar counterfactual trends or eliminate unmeasured differences. Comparability must be assessed according to the chosen design.

Misconception

Any Untreated Group Can Serve as a Control

Untreated units may differ systematically in eligibility, readiness, resources, or potential outcomes. The comparison must support the intended counterfactual.

Misconception

Matching Automatically Removes Selection Bias

Matching may improve balance on measured pretreatment variables but does not guarantee comparability on unmeasured confounders.

Misconception

A Nonsignificant Baseline Test Proves the Groups Are Equivalent

Failure to reject a baseline difference does not demonstrate equivalence. Such tests may have low power and do not address unmeasured confounding.

Misconception

Comparison Groups Should Be Chosen According to Which Produces the Largest Effect

Outcome-driven comparison selection introduces analytical flexibility and can undermine credibility. Comparisons should be justified using pretreatment evidence and design assumptions.

Misconception

More Control Variables Always Improve Causal Validity

Some variables may be affected by treatment or act as colliders. Adjustment should follow causal reasoning rather than indiscriminate inclusion.

06 · What This Means for You

Select Comparison Units According to the Counterfactual They Must Represent

Begin by specifying the causal effect and design. Then investigate the treatment assignment mechanism and identify the characteristics or outcome patterns relevant to that design's assumptions.

Use pretreatment evidence to justify comparison selection, examine whether treatment and comparison units have appropriate overlap, and investigate concurrent events or spillover.

Where several comparison groups are plausible, prespecify the primary choice and use alternatives to assess sensitivity rather than selecting the most favorable estimate.

A practical comparison-group framework

If using difference-in-differences
Prioritize credible counterfactual outcome trends and examine the assignment mechanism and concurrent changes.
If using regression discontinuity
Focus on units near the cutoff and assess continuity and manipulation assumptions.
If using matching or weighting
Assess pretreatment confounder measurement, overlap, and the implications for the target estimand.
If using a controlled interrupted time series
Choose a series that reflects relevant background changes and is not affected by the intervention.
If no comparison supports a defensible counterfactual
Reconsider the design or limit conclusions to what the available data can establish.

A credible comparison group is not necessarily the group that looks most similar in a descriptive table. It is the group whose observed outcomes can most plausibly inform the untreated potential outcomes required by the research question.

07 · A Quick Checklist

Before Finalizing a Quasi-Experimental Comparison Group

Before selecting the comparison, check:
Define the causal estimand and the population whose counterfactual outcomes must be estimated.
Investigate how treated and comparison units came to receive different conditions.
Confirm that eligibility and outcome definitions are appropriate and comparable.
Examine relevant pretreatment characteristics and outcome trajectories.
Assess the design-specific identification assumptions rather than relying only on baseline similarity.
Identify plausible unmeasured confounders and differences in institutional policies.
Evaluate treatment contamination, spillover, and concurrent interventions.
Assess overlap and avoid unsupported extrapolation where relevant.
Prespecify comparison selection and appropriate sensitivity analyses.
Explain why the comparison represents a plausible counterfactual rather than merely an available untreated group.
08 · Frequently Asked Questions

Frequently Asked Questions About Quasi-Experimental Comparison Groups

Does a quasi-experimental comparison group need to be identical to the intervention group?

No. The required comparability depends on the design. For example, difference-in-differences concerns counterfactual trends rather than identical baseline outcome levels.

Can a comparison group have different baseline scores?

Yes. Different baseline levels may be compatible with a credible difference-in-differences design if the relevant counterfactual trend assumptions are defensible.

Is matching enough to create a valid comparison group?

Not automatically. Matching addresses observed pretreatment characteristics under particular assumptions but does not guarantee the absence of unmeasured confounding.

Can another school or university serve as a comparison?

Potentially. Researchers must investigate differences in treatment selection, eligibility, outcome trends, institutional policies, and measurement procedures.

Can later intervention adopters serve as controls?

They may serve as not-yet-treated comparisons under appropriate staggered adoption assumptions, provided anticipation, timing selection, and treatment-effect heterogeneity are addressed.

Do nonsignificant baseline differences establish comparability?

No. Statistical nonsignificance does not prove equivalence and cannot establish that unmeasured characteristics or counterfactual trajectories are comparable.

What if no suitable comparison group exists?

Researchers may consider another identification strategy, such as interrupted time series or regression discontinuity where appropriate. If no credible counterfactual is available, causal conclusions should be limited.

Can a comparison group be too different to use?

Yes. Severe differences in eligibility, exposure, measurement, or potential outcome determinants may make a comparison implausible or require extrapolation unsupported by the data.

09 · The Bottom Line

A Credible Comparison Group Must Represent a Defensible Untreated Counterfactual

The Bottom Line

A credible quasi-experimental comparison group is one whose outcomes can reasonably inform what would have happened to the treated population without intervention, under the assumptions of the selected design.

Baseline similarity, matching, and the presence of untreated units may be useful, but none independently establishes validity. Investigate treatment assignment, pretreatment trajectories, measurement consistency, confounding, and spillover before relying on a comparison for causal inference.

10 · Sources and Further Reading

Methodological Literature on Comparison Groups and Counterfactual Identification

11 · Cite this Guide

How to Cite This Guide

This guide is intended to be read, shared, and used in research, teaching, and academic work. If you draw on its ideas, explanations, or other content, please acknowledge the source by citing the guide. Doing so gives appropriate credit and helps your readers locate the original resource.

Has the Field Guide helped your research?

If a guide helped clarify a question, inform a research decision, or move your work forward, I would love to hear about your experience. Your story may also help other researchers discover the Field Guide.

Share Your Experience
Takes only a few minutes